Pressing financial resource for new medicine development

KPMA insisted that reimbursement system of actual market price should be come to stay and low-profit structure should be improved for the purpose of preventing unreasonable price from reducing and settling orderly medicine trading to improve research development power of pharmaceutical manufacturing company.

Public relations committee of KPMA insisted that our country should prepare diversi...